India-U.S. Trade at a Crossroads: What Rising U.S. Tariffs Mean for Indian Exports This article decodes the math behind Washington’s tariff strategy, and evaluates how different Indian sectors may be impacted.
The Gensol Crisis: A Cautionary Tale for Investors The Gensol–BluSmart saga is a crash course in what not to ignore as a retail investor. Read here to know more.
Why We Added a Safety Net to the CANSLIM-esque smallcase We upgraded the CANSLIM-esque smallcase with asset allocation—same growth, lower drawdowns. Here’s the why.
Lipstick, Lattes & Loose Change: The Economy’s Strangest Early Warning System? Unusual signals—from lipstick to lattes—offering a satirical take on how the economy shows up in everyday behavior.
India-U.S. Trade at a Crossroads: What Rising U.S. Tariffs Mean for Indian Exports This article decodes the math behind Washington’s tariff strategy, and evaluates how different Indian sectors may be impacted.
US Tariffs Rattle Global Markets, Strain Economies India Hit by 26% US Tariff; Markets Slide as Global Trade Tensions Escalate.
India-U.S. Trade Surplus Under Fire: Pharma Sector in the Crosshairs The U.S. is targeting India’s trade surplus with new tariffs. The high-value pharmaceutical sector now risks major disruption.